How CordenPharma’s AmbioPharm deal strengthens U.S. and China peptide API supply
Find out how CordenPharma’s AmbioPharm deal expands peptide API capacity and reshapes global CDMO competition.
How Kenox Pharmaceuticals is targeting the OINDP CDMO gap with integrated clinical manufacturing
Kenox Pharmaceuticals announces clinical manufacturing readiness for inhaled and nasal drug products. What this means for OINDP development timelines and IVBE strategy.